ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 79 filers reported holding ALLOVIR INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,817,289 | -35.7% | 9,682,460 | +1.7% | 0.00% | -33.3% |
| Q2 2023 | $32,373,243 | -44.3% | 9,521,542 | -35.4% | 0.00% | 0.0% |
| Q1 2023 | $58,072,676 | +60.7% | 14,739,258 | +109.2% | 0.00% | -25.0% |
| Q4 2022 | $36,147,893 | -37.1% | 7,046,373 | -3.3% | 0.00% | -33.3% |
| Q3 2022 | $57,485,000 | +105.1% | 7,285,836 | +1.4% | 0.01% | +100.0% |
| Q2 2022 | $28,033,000 | -47.7% | 7,187,884 | -9.4% | 0.00% | -25.0% |
| Q1 2022 | $53,571,000 | -43.9% | 7,936,530 | +7.5% | 0.00% | -42.9% |
| Q4 2021 | $95,511,000 | -48.0% | 7,381,063 | +0.7% | 0.01% | -53.3% |
| Q3 2021 | $183,684,000 | +44.3% | 7,329,782 | +13.7% | 0.02% | +50.0% |
| Q2 2021 | $127,259,000 | -21.8% | 6,446,751 | -7.4% | 0.01% | -28.6% |
| Q1 2021 | $162,837,000 | -39.6% | 6,958,852 | -3.0% | 0.01% | -41.7% |
| Q4 2020 | $269,574,000 | +55.7% | 7,177,546 | +8.3% | 0.02% | +33.3% |
| Q3 2020 | $173,170,000 | – | 6,626,438 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $28,611 | 1.60% |
| GMT CAPITAL CORP | 2,758,846 | $14,152,880 | 0.65% |
| SVB FINANCIAL GROUP | 43,019 | $220,687 | 0.60% |
| Regency Capital Management Inc.\DE | 75,025 | $384,878 | 0.44% |
| Redmile Group, LLC | 1,907,969 | $9,787,881 | 0.40% |
| Samsara BioCapital, LLC | 82,336 | $422,384 | 0.09% |
| Alkeon Capital Management | 4,605,104 | $23,624,184 | 0.09% |
| Woodline Partners LP | 1,087,090 | $5,576,772 | 0.08% |
| XTX Topco Ltd | 53,422 | $274,055 | 0.06% |
| Virtus ETF Advisers LLC | 20,906 | $107,248 | 0.06% |